223 related articles for article (PubMed ID: 2448762)
21. Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies.
Chemaly RF; Shah DP; Boeckh MJ
Clin Infect Dis; 2014 Nov; 59 Suppl 5(Suppl 5):S344-51. PubMed ID: 25352629
[TBL] [Abstract][Full Text] [Related]
22. Antiviral drugs in healthy children.
Margo KL; Shaughnessy AF
Am Fam Physician; 1998 Mar; 57(5):1073-7. PubMed ID: 9518953
[TBL] [Abstract][Full Text] [Related]
23. Ribavirin (virazole): a novel antiviral agent against viral respiratory tract infections.
Ahmed ME; Branch RA
Ration Drug Ther; 1986 Nov; 20(11):1-3. PubMed ID: 3588934
[No Abstract] [Full Text] [Related]
24. Measures for control of influenza.
Couch RB
Pharmacoeconomics; 1999; 16 Suppl 1():41-5. PubMed ID: 10623375
[TBL] [Abstract][Full Text] [Related]
25. What's new in the treatment of viral respiratory infections in children. Part II.
Chonmaitree T; Truant AL
Tex Med; 1985 Feb; 81(2):43-4. PubMed ID: 3885462
[No Abstract] [Full Text] [Related]
26. Amantadine and rimantadine for influenza A in adults.
Jefferson T; Demicheli V; Di Pietrantonj C; Rivetti D
Cochrane Database Syst Rev; 2006 Apr; 2006(2):CD001169. PubMed ID: 16625539
[TBL] [Abstract][Full Text] [Related]
27. Antiviral agents in influenza--summary of Influenza Workshop VIII.
Couch RB; Jackson GG
J Infect Dis; 1976 Nov; 134(5):516-27. PubMed ID: 993622
[No Abstract] [Full Text] [Related]
28. Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections.
Tominack RL; Hayden FG
Infect Dis Clin North Am; 1987 Jun; 1(2):459-78. PubMed ID: 3332798
[TBL] [Abstract][Full Text] [Related]
29. Clinical use of antiviral drugs.
Nahata MC
Drug Intell Clin Pharm; 1987 May; 21(5):399-405. PubMed ID: 3556126
[TBL] [Abstract][Full Text] [Related]
30. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults.
Englund JA; Champlin RE; Wyde PR; Kantarjian H; Atmar RL; Tarrand J; Yousuf H; Regnery H; Klimov AI; Cox NJ; Whimbey E
Clin Infect Dis; 1998 Jun; 26(6):1418-24. PubMed ID: 9636873
[TBL] [Abstract][Full Text] [Related]
31. Ribavirin treatment of viral pneumonitis in severe combined immunodeficiency disease.
Gelfand EW; McCurdy D; Rao CP; Middleton PJ
Lancet; 1983 Sep; 2(8352):732-3. PubMed ID: 6136856
[No Abstract] [Full Text] [Related]
32. Viral respiratory infections in the community: epidemiology, agents, and interventions.
Monto AS
Am J Med; 1995 Dec; 99(6B):24S-27S. PubMed ID: 8585553
[TBL] [Abstract][Full Text] [Related]
33. [Antiviral agents in viral respiratory infections].
Wu E; Grado C
Rev Chil Pediatr; 1988; 59(3):192-9. PubMed ID: 3075062
[No Abstract] [Full Text] [Related]
34. Antivirals for influenza: what is their role in the older patient?
Dumyati G; Falsey AR
Drugs Aging; 2002; 19(10):777-86. PubMed ID: 12390054
[TBL] [Abstract][Full Text] [Related]
35. A perspective from controlled investigations of chemotherapy for viral respiratory infections.
Jackson GG
J Infect Dis; 1976 Jun; 133 Suppl(Suppl 2):A83-92. PubMed ID: 778309
[TBL] [Abstract][Full Text] [Related]
36. Clinical considerations in the diagnosis of viral respiratory infections.
Cates KL
Diagn Microbiol Infect Dis; 1986 Mar; 4(3 Suppl):23S-33S. PubMed ID: 3516546
[TBL] [Abstract][Full Text] [Related]
37. The possible chemotherapy of respiratory virus diseases.
Tyrrell DA
Sci Basis Med Annu Rev; 1969; ():294-319. PubMed ID: 4917842
[No Abstract] [Full Text] [Related]
38. Antiviral therapy for respiratory viral infections in immunocompromised patients.
Shahani L; Ariza-Heredia EJ; Chemaly RF
Expert Rev Anti Infect Ther; 2017 Apr; 15(4):401-415. PubMed ID: 28067078
[TBL] [Abstract][Full Text] [Related]
39. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study.
Hall CB; McBride JT; Walsh EE; Bell DM; Gala CL; Hildreth S; Ten Eyck LG; Hall WJ
N Engl J Med; 1983 Jun; 308(24):1443-7. PubMed ID: 6343860
[TBL] [Abstract][Full Text] [Related]
40. Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?
Brooks MJ; Sasadeusz JJ; Tannock GA
Curr Opin Pulm Med; 2004 May; 10(3):197-203. PubMed ID: 15071371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
